Home › Funds › Royce & Associates › UTMD
Royce & Associates position in UTMD
UTAH MED PRODS INC · Health Care
Latest position (Q1 2025)41.96K sh
Reported value held$2.35M
Portfolio Weight0.03%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 31.79K | $2.95M | New |
| Q4 2021 | 31.78K | $3.18M | Hold |
| Q1 2022 | 31.86K | $2.86M | Hold |
| Q2 2022 | 31.91K | $2.74M | Hold |
| Q3 2022 | 31.98K | $2.73M | Hold |
| Q4 2022 | 29.96K | $3.01K | Reduce |
| Q1 2023 | 32.66K | $3.10K | Add |
| Q2 2023 | 32.67K | $3.04M | Hold |
| Q3 2023 | 32.72K | $2.81M | Hold |
| Q4 2023 | 15.85K | $1.33M | Reduce |
| Q1 2024 | 16.20K | $1.15M | Add |
| Q2 2024 | 16.20K | $1.08M | Hold |
| Q3 2024 | 16.20K | $1.08M | Hold |
| Q4 2024 | 41.96K | $2.58M | Add |
| Q1 2025 | 41.96K | $2.35M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding UTMD
- BlackRock Inc 203.69K sh · $14.05M · Q2 2026
- Renaissance Technologies 175.81K sh · $12.13M · Q2 2026
- Vanguard Group 175.97K sh · $9.85M · Q4 2025
- Geode Capital Management 108.05K sh · $7.45M · Q2 2026
- Morgan Stanley 69.67K sh · $4.81M · Q2 2026
- UBS Group AG 34.37K sh · $2.37M · Q2 2026
- BNY Mellon 34.26K sh · $2.36M · Q2 2026
- Northern Trust Corp 30.10K sh · $2.08M · Q2 2026
- Fidelity Management & Research (FMR) 18.07K sh · $1.25M · Q2 2026
- AQR Capital Management 14.99K sh · $1.03M · Q2 2026
- Charles Schwab Investment Management 11.12K sh · $767.13K · Q2 2026
- D. E. Shaw & Co 8.73K sh · $602.54K · Q2 2026